MMP16 expression is associated with age, tumor size, histology, clinical stages, lymph node metastasis status, PR status, HER2 status, non-TNBC, and BRCA1 status (P < 0.05), but not with other clinical pathological parameters. Here, PGR is linked to metastasis.